Macrobid Course for Uncomplicated UTI
For uncomplicated cystitis in women, prescribe nitrofurantoin monohydrate/macrocrystals (Macrobid) 100 mg twice daily for 5 days. 1, 2
Standard Dosing Regimen
- Nitrofurantoin monohydrate/macrocrystals (Macrobid): 100 mg orally twice daily for 5 days is the guideline-recommended first-line therapy for uncomplicated UTI in women 1, 2
- The 5-day regimen achieves clinical cure rates of 88-93% and bacterial cure rates of 81-92% 2
- This formulation allows twice-daily dosing due to its dual-release properties, improving compliance compared to older formulations requiring four-times-daily dosing 3
When to Extend Duration
- Consider 7 days of therapy if symptoms persist at day 5 or in specific clinical scenarios where treatment response may be slower 2, 4
- The American College of Physicians and IDSA guidelines support 5-7 day courses, with 5 days being optimal for most uncomplicated cases 1, 2
Special Dosing Situations
- For enterococcal UTIs (including VRE): Use 100 mg four times daily (every 6 hours) rather than twice daily 2, 3
- For men with uncomplicated UTI: Limited data support 7-14 days of therapy, though specific evidence is sparse 4
- For children ≥12 years: 100 mg twice daily; for children <12 years: 5-7 mg/kg/day divided into 4 doses (maximum 100 mg/dose) for 7 days 2
Critical Contraindications
- Do not use if creatinine clearance <60 mL/min 3
- Avoid if early pyelonephritis is suspected - nitrofurantoin does not achieve adequate tissue concentrations for upper tract infections 2
- Contraindicated in last trimester of pregnancy 3
Comparison to Alternative First-Line Agents
The 5-day nitrofurantoin regimen is equivalent in efficacy to:
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (90% clinical cure for both) 2
- Ciprofloxacin 7-day regimens (95% cure rate), though fluoroquinolones should be reserved for more invasive infections 2, 4
Nitrofurantoin maintains a resistance rate of only 2.3% compared to 24% for fluoroquinolones and 29% for trimethoprim-sulfamethoxazole, making it an excellent fluoroquinolone-sparing option 5
Common Pitfalls to Avoid
- Do not prescribe for pyelonephritis or perinephric abscess - inadequate tissue penetration 2
- Do not extend beyond 7 days for uncomplicated cystitis unless symptoms persist, as longer courses increase adverse effects without improving efficacy 2
- Do not use in patients with renal impairment (CrCl <60 mL/min) due to risk of accumulation and serious adverse effects including pulmonary reactions and polyneuropathy 3
- Common side effects include nausea and headache (5.6-34% adverse event rate), which patients should be counseled about 2, 3